Developer docs
API playgroundTry for free, no card

Search company profiles

Concert

Full company profile

uuid000asq9

Namestring
Concert
Legal namestring
Concert Genetics, Inc.
Websiteurl
concert.co
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Concert is a Nashville-based healthcare technology company that builds payment accuracy and test order management infrastructure for the U.S. precision diagnostics market. Founded in 2010 as NextGxDx (rebranded to Concert Genetics in 2017 and to Concert in May 2024), the company maintains a proprietary catalog of 160,000+ genetic testing products, the GTU® (Genetic Testing Unit) Test Identifier standard, and the Concert Coding Engine that translates each genetic test into a single code or code combination to eliminate ambiguity in claims coding. Its platform combines clinical criteria, coding rules, medical policy content, and machine-readable guidelines delivered via cloud-based API for integration into EHR, prior authorization, and pre-payment claim editing workflows.

The company serves three primary customer segments: health plans (payment accuracy, claim editing, prior authorization, utilization management), hospitals and health systems (test ordering guidance, insurance alignment, clinical decision support), and clinical laboratories (coding standardization, reimbursement support, and market access). Revenue is generated primarily through enterprise software subscriptions sold to health plans and large healthcare organizations, supplemented by a free tier for the public test registry. The free tier functions as a top-of-funnel acquisition channel, while paid enterprise contracts are quote-based, typically structured as annual subscriptions.

Distribution is heavily partner-mediated. Concert's clinical content, GTU identifiers, and coding standards are embedded inside Availity's End-to-End Authorization solution (covering 95%+ of U.S. payers and 3M+ providers), EviCore by Evernorth's authorization guidelines, and Lyric's payment accuracy platform (Lyric delivers over $14 billion in annual payment accuracy savings). These channel partnerships, combined with direct enterprise sales, form the company's go-to-market architecture and are the primary mechanism by which Concert reaches enterprise healthcare buyers at scale.

Short descriptiontext

Concert is a Nashville-based healthcare technology company that provides payment accuracy, coding, and test order management software for genetic and precision diagnostics, serving health plans, hospitals, and laboratories through its GTU Test Identifier, Coding Engine, and machine-readable clinical policy platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNashville, United States
HQ citystring
Nashville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
payment accuracy software, genetic test coding, medical policy automation, diagnostic benefit programs, precision health platform
NAICS code1 code
  • Testing Laboratories and Services54138
Product category
Healthcare Payment Accuracy Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Enterprise Software Subscriptions
TypeSubscription Recurring
Description

Concert provides software, policy, and coding solutions to health plans, providers, and laboratories through enterprise licensing arrangements. The platform is sold as an integrated solution with cloud-based deployment and API access.

concert.co
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Free tier for basic access to test registry and policies
ModelFreemiumBilling cadenceAnnual
Notes

Free accounts available for viewing Concert test catalog, coding standards, and reference medical policies. Premium enterprise features and integrations are offered via paid subscription.

concert.co
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Concert delivers a cloud-based, integrated precision health payment accuracy platform that combines a catalog of 160,000+ genetic testing products, the proprietary GTU Test Identifier, the Concert Coding Engine, and machine-readable medical policies. The platform is sold as enterprise software to health plans, providers, and laboratories, enabling automated claim editing, prior authorization, test order management, and diagnostic benefit program administration via cloud API integrations into clinical and financial workflows.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Reduces administrative burden through automation of prior authorization and claim editing processes
+2 more records
Product overview1 text field

Concert offers a unified precision health payment accuracy platform consisting of multiple integrated modules. The core platform harmonizes evidence, policy, coding, and payment through products including the GTU Test Identifier (standardized test identification), Payment Accuracy (automated claim editing), Medical Policy (clinical criteria), Test Order Management, Network Management, and Test Result Integration. The Concert Coding Engine translates genetic tests into standardized code combinations. These solutions are delivered via cloud-based API integration into clinical and financial workflows, serving health plans, providers, and laboratories.

Product and service10 records
1Precision Health Payment Accuracy Platform
CategoryPayment Accuracy Platform
Description

Cloud-based, integrated platform combining tests, coding, evidence, policy, and payment rules to provide clarity in precision health. Delivers evidence-based policy and real-time intelligence directly into clinical and financial workflows for health plans, providers, and laboratories.

2GTU Test Identifier
CategoryTest Identification and Coding
Description

A proprietary test identifier that standardizes genetic test identification across the healthcare ecosystem, enabling consistent communication for ordering, resulting, coding, coverage, and payment of genetic tests.

3Payment Accuracy
CategoryPayment Accuracy
Description

Solution for harmonizing guidelines, policy, coding, and payment for automation that health plans and providers trust. Delivers automated claim editing and payment accuracy for genetic and laboratory testing.

4Medical Policy
CategoryMedical Policy Content
Description

Machine-readable, evidence-based clinical criteria for advanced diagnostics including genetic testing and infectious disease testing, providing clinical decision support content deployable via API into EHR, prior authorization, and claim editing workflows.

5Test Order Management
CategoryTest Order Management
Description

System for guiding the genetic test order management process, enabling efficiency, stewardship, and insurance alignment for providers and hospitals ordering precision diagnostic tests.

6Network Management
CategoryNetwork Management
Description

Solution for managing provider network considerations related to diagnostic and precision health services.

7Test Result Integration
CategoryTest Result Integration
Description

Solution enabling integration of test results into clinical workflows and systems used by providers and laboratories.

8Diagnostic Benefit Program
CategoryDiagnostic Benefit Management
Description

Solution for health plans to manage laboratory testing, covering genetic testing, outpatient infectious disease testing, and broader diagnostic services through integrated policy and payment accuracy.

9Concert Coding Engine
CategoryTest Coding Software
Description

Solution that translates each genetic test into a single code or code combination to eliminate ambiguity and inconsistency in genetic test claims coding across the industry.

10Test Registry
CategoryTest Registry
Description

Free searchable catalog of genetic tests, coding standards, and reference medical policies available through Concert's online platform, providing transparency into the genetic testing market.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-09
Description

Partnership to digitize and automate prior authorization and payment processes for genetic tests. Integrates Concert's clinical criteria, coding standards, and GTU test identifier with Availity's End-to-End Authorization solution. Goal is to enable more consistent, transparent, and instantaneous prior authorizations, reducing administrative burden in precision medicine delivery. Availity is the nation's leading real-time health information network with connections to over 95% of payers and more than 3 million providers.

2EviCore
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-05-21
Description

Streamline prior authorization for genetic testing by integrating Concert's coding standards and GTU test ID with EviCore's clinical guidelines. Alignment of clinical and administrative guidelines enables fewer, simpler authorizations and improves efficiency and transparency. EviCore is part of Evernorth and provides medical policies and authorization guidelines.

concert.co
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-05-01
Description

Expanded partnership to deliver the Diagnostics Module (formerly Genetic Testing Module) for laboratory payment accuracy across a growing scope of advanced and routine laboratory tests. Addresses outpatient infectious disease testing, the largest area of outpatient lab spend for many health plans. Lyric is an AI-first leader in payment accuracy delivering over $14 billion of annual savings with recognition from KLAS as a 'true partner' with top customer satisfaction scores.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-06-07
Description

Initial partnership to make Concert's genetic test payment accuracy capabilities available through Lyric's ClaimsXten product, enabling claim editing for genetic tests.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Availity is the nation's largest real-time health information network connecting 95%+ of payers with 3M+ providers for prior authorization and clinical workflows. Comparable to Concert as a healthcare data and authorization infrastructure provider, and also a strategic partner.

TypeEmerging player
Description

Edifecs provides healthcare data interoperability, payment integrity, and clinical content solutions for payers and providers. Comparable to Concert in healthcare data integration and policy-driven claim editing, with broader enterprise footprint.

TypeEmerging player
Description

Infinx provides AI-driven prior authorization and revenue cycle management for healthcare providers and payers, with overlap to Concert's prior authorization automation focus. A smaller but fast-growing peer in the diagnostic test authorization category.

TypeBroad incumbent
Description

Change Healthcare, now part of Optum, is a leading healthcare technology vendor providing claim editing, payment accuracy, and revenue cycle solutions. Highly comparable to Concert in payment accuracy and clinical content delivery, but at vastly greater scale and across all clinical domains.

TypeDirect peer
Description

Lyric is an AI-first payment accuracy company delivering $14B+ in annual savings, and is itself a major Concert partner (ClaimsXten/Diagnostics Module). Comparable to Concert in payment accuracy and claim editing, with AI-driven capabilities and broader lab/payment categories.

TypeBroad incumbent
Description

Optum is the largest healthcare services and innovation arm of UnitedHealth Group, offering payment accuracy, claim editing, and analytics at massive scale through Change Healthcare. Comparable to Concert as a broad incumbent in payment accuracy with overlapping capabilities, though Optum's portfolio extends far beyond diagnostics.

TypeEmerging player
Description

Zynx Health provides evidence-based clinical decision support and care guidance content for healthcare organizations. Comparable to Concert's medical policy content, focused on clinical content delivery to EHR and workflow systems.

TypeDirect peer
Description

MCG provides evidence-based clinical decision support and care guidelines used by health plans and providers for utilization management and prior authorization. Highly comparable to Concert's clinical policy content product, with similar integration into payer workflows.

9EviCore (Evernorth/Cigna)
TypeDirect peer
Description

EviCore is a leading medical benefits management provider for prior authorization and clinical guidelines, and is itself a Concert partner. Highly comparable as a peer in clinical policy-driven prior authorization, particularly for advanced diagnostics and specialty services.

TypeDirect peer
Description

Cotiviti specializes in payment accuracy, claim editing, and analytics for healthcare payers, with deep capabilities in clinical and coding content for medical and pharmacy claims. A direct peer to Concert in payment integrity, though Cotiviti operates at much larger scale across broader claim categories.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Concert

Healthcare Payment Accuracy Softwareconcert.co

Concert is a Nashville-based healthcare technology company that provides payment accuracy, coding, and test order management software for genetic and precision diagnostics, serving health plans, hospitals, and laboratories through its GTU Test Identifier, Coding Engine, and machine-readable clinical policy platform.

What Concert does

Concert is a Nashville-based healthcare technology company that builds payment accuracy and test order management infrastructure for the U.S. precision diagnostics market. Founded in 2010 as NextGxDx (rebranded to Concert Genetics in 2017 and to Concert in May 2024), the company maintains a proprietary catalog of 160,000+ genetic testing products, the GTU® (Genetic Testing Unit) Test Identifier standard, and the Concert Coding Engine that translates each genetic test into a single code or code combination to eliminate ambiguity in claims coding. Its platform combines clinical criteria, coding rules, medical policy content, and machine-readable guidelines delivered via cloud-based API for integration into EHR, prior authorization, and pre-payment claim editing workflows.

The company serves three primary customer segments: health plans (payment accuracy, claim editing, prior authorization, utilization management), hospitals and health systems (test ordering guidance, insurance alignment, clinical decision support), and clinical laboratories (coding standardization, reimbursement support, and market access). Revenue is generated primarily through enterprise software subscriptions sold to health plans and large healthcare organizations, supplemented by a free tier for the public test registry. The free tier functions as a top-of-funnel acquisition channel, while paid enterprise contracts are quote-based, typically structured as annual subscriptions.

Distribution is heavily partner-mediated. Concert's clinical content, GTU identifiers, and coding standards are embedded inside Availity's End-to-End Authorization solution (covering 95%+ of U.S. payers and 3M+ providers), EviCore by Evernorth's authorization guidelines, and Lyric's payment accuracy platform (Lyric delivers over $14 billion in annual payment accuracy savings). These channel partnerships, combined with direct enterprise sales, form the company's go-to-market architecture and are the primary mechanism by which Concert reaches enterprise healthcare buyers at scale.

Concert firmographics

Firmographics
Name
Concert
Legal name
Concert Genetics, Inc.
Website
https://concert.co
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
Concert is a Nashville-based healthcare technology company that provides payment accuracy, coding, and test order management software for genetic and precision diagnostics, serving health plans, hospitals, and laboratories through its GTU Test Identifier, Coding Engine, and machine-readable clinical policy platform.
Ownership category
akta.pro rank

Where Concert is headquartered

Location

Headquarters

HQ city
Nashville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Concert business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Enterprise Software Subscriptions: Concert provides software, policy, and coding solutions to health plans, providers, and laboratories through enterprise licensing arrangements. The platform is sold as an integrated solution with cloud-based deployment and API access.

Pricing tiers

ModelBillingPrice
FreemiumAnnualFree tier for basic access to test registry and policies

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Concert product offering

Product offering

Core offering

Concert delivers a cloud-based, integrated precision health payment accuracy platform that combines a catalog of 160,000+ genetic testing products, the proprietary GTU Test Identifier, the Concert Coding Engine, and machine-readable medical policies. The platform is sold as enterprise software to health plans, providers, and laboratories, enabling automated claim editing, prior authorization, test order management, and diagnostic benefit program administration via cloud API integrations into clinical and financial workflows.

Product overview

Concert offers a unified precision health payment accuracy platform consisting of multiple integrated modules. The core platform harmonizes evidence, policy, coding, and payment through products including the GTU Test Identifier (standardized test identification), Payment Accuracy (automated claim editing), Medical Policy (clinical criteria), Test Order Management, Network Management, and Test Result Integration. The Concert Coding Engine translates genetic tests into standardized code combinations. These solutions are delivered via cloud-based API integration into clinical and financial workflows, serving health plans, providers, and laboratories.

Differentiator

Problem solved

Functional benefit

Products and services

  • Precision Health Payment Accuracy Platform Cloud-based, integrated platform combining tests, coding, evidence, policy, and payment rules to provide clarity in precision health. Delivers evidence-based policy and real-time intelligence directly into clinical and financial workflows for health plans, providers, and laboratories.
  • GTU Test Identifier A proprietary test identifier that standardizes genetic test identification across the healthcare ecosystem, enabling consistent communication for ordering, resulting, coding, coverage, and payment of genetic tests.
  • Payment Accuracy Solution for harmonizing guidelines, policy, coding, and payment for automation that health plans and providers trust. Delivers automated claim editing and payment accuracy for genetic and laboratory testing.
  • Medical Policy Machine-readable, evidence-based clinical criteria for advanced diagnostics including genetic testing and infectious disease testing, providing clinical decision support content deployable via API into EHR, prior authorization, and claim editing workflows.
  • Test Order Management System for guiding the genetic test order management process, enabling efficiency, stewardship, and insurance alignment for providers and hospitals ordering precision diagnostic tests.
  • Network Management Solution for managing provider network considerations related to diagnostic and precision health services.
  • Test Result Integration Solution enabling integration of test results into clinical workflows and systems used by providers and laboratories.
  • Diagnostic Benefit Program Solution for health plans to manage laboratory testing, covering genetic testing, outpatient infectious disease testing, and broader diagnostic services through integrated policy and payment accuracy.
  • Concert Coding Engine Solution that translates each genetic test into a single code or code combination to eliminate ambiguity and inconsistency in genetic test claims coding across the industry.
  • Test Registry Free searchable catalog of genetic tests, coding standards, and reference medical policies available through Concert's online platform, providing transparency into the genetic testing market.

Quantifiable outcome

  • Reduces administrative burden through automation of prior authorization and claim editing processes
  • +2 more outcomes

Companies that use Concert

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Concert technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability4 records

Feature4 records

Concert partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • AvailitycoreStrategic or Co-development Partner · 9 January 2025Partnership to digitize and automate prior authorization and payment processes for genetic tests. Integrates Concert's clinical criteria, coding standards, and GTU test identifier with Availity's End-to-End Authorization solution. Goal is to enable more consistent, transparent, and instantaneous prior authorizations, reducing administrative burden in precision medicine delivery. Availity is the nation's leading real-time health information network with connections to over 95% of payers and more than 3 million providers.
  • EviCorecoreStrategic or Co-development Partner · 21 May 2024Streamline prior authorization for genetic testing by integrating Concert's coding standards and GTU test ID with EviCore's clinical guidelines. Alignment of clinical and administrative guidelines enables fewer, simpler authorizations and improves efficiency and transparency. EviCore is part of Evernorth and provides medical policies and authorization guidelines.
  • LyriccoreStrategic or Co-development Partner · 1 May 2024Expanded partnership to deliver the Diagnostics Module (formerly Genetic Testing Module) for laboratory payment accuracy across a growing scope of advanced and routine laboratory tests. Addresses outpatient infectious disease testing, the largest area of outpatient lab spend for many health plans. Lyric is an AI-first leader in payment accuracy delivering over $14 billion of annual savings with recognition from KLAS as a 'true partner' with top customer satisfaction scores.
  • Lyric (formerly ClaimsXten Portfolio)coreStrategic or Co-development Partner · 7 June 2023Initial partnership to make Concert's genetic test payment accuracy capabilities available through Lyric's ClaimsXten product, enabling claim editing for genetic tests.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Concert competitors and assessment

Company assessment

Direct peers

  • Availity: Availity is the nation's largest real-time health information network connecting 95%+ of payers with 3M+ providers for prior authorization and clinical workflows. Comparable to Concert as a healthcare data and authorization infrastructure provider, and also a strategic partner.
  • Lyric (formerly ClaimsXten): Lyric is an AI-first payment accuracy company delivering $14B+ in annual savings, and is itself a major Concert partner (ClaimsXten/Diagnostics Module). Comparable to Concert in payment accuracy and claim editing, with AI-driven capabilities and broader lab/payment categories.
  • MCG (Hearst Health): MCG provides evidence-based clinical decision support and care guidelines used by health plans and providers for utilization management and prior authorization. Highly comparable to Concert's clinical policy content product, with similar integration into payer workflows.
  • EviCore (Evernorth/Cigna): EviCore is a leading medical benefits management provider for prior authorization and clinical guidelines, and is itself a Concert partner. Highly comparable as a peer in clinical policy-driven prior authorization, particularly for advanced diagnostics and specialty services.
  • Cotiviti: Cotiviti specializes in payment accuracy, claim editing, and analytics for healthcare payers, with deep capabilities in clinical and coding content for medical and pharmacy claims. A direct peer to Concert in payment integrity, though Cotiviti operates at much larger scale across broader claim categories.

Emerging players

  • Edifecs: Edifecs provides healthcare data interoperability, payment integrity, and clinical content solutions for payers and providers. Comparable to Concert in healthcare data integration and policy-driven claim editing, with broader enterprise footprint.
  • Infinx: Infinx provides AI-driven prior authorization and revenue cycle management for healthcare providers and payers, with overlap to Concert's prior authorization automation focus. A smaller but fast-growing peer in the diagnostic test authorization category.
  • Zynx Health: Zynx Health provides evidence-based clinical decision support and care guidance content for healthcare organizations. Comparable to Concert's medical policy content, focused on clinical content delivery to EHR and workflow systems.

Broad incumbents

  • Change Healthcare (Optum): Change Healthcare, now part of Optum, is a leading healthcare technology vendor providing claim editing, payment accuracy, and revenue cycle solutions. Highly comparable to Concert in payment accuracy and clinical content delivery, but at vastly greater scale and across all clinical domains.
  • Optum (UnitedHealth Group): Optum is the largest healthcare services and innovation arm of UnitedHealth Group, offering payment accuracy, claim editing, and analytics at massive scale through Change Healthcare. Comparable to Concert as a broad incumbent in payment accuracy with overlapping capabilities, though Optum's portfolio extends far beyond diagnostics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Concert social profiles

Digital presence

Concert financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Concert leadership team

Management profile

Number of profiles

Profiles3 records

Concert funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Concert M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Concert

What does Concert do?

Concert delivers a cloud-based, integrated precision health payment accuracy platform that combines a catalog of 160,000+ genetic testing products, the proprietary GTU Test Identifier, the Concert Coding Engine, and machine-readable medical policies. The platform is sold as enterprise software to health plans, providers, and laboratories, enabling automated claim editing, prior authorization, test order management, and diagnostic benefit program administration via cloud API integrations into clinical and financial workflows.

Is Concert a public or private company?

Concert is a private company. It is classified as venture growth investor backed and is currently operating.

When was Concert founded?

Concert was founded in 2010. It employs 11 to 50 people.

Where is Concert based?

Concert is headquartered in Nashville, United States, in the North America region.

How does Concert make money?

One revenue line is on record: enterprise Software Subscriptions.

Who are Concert's main competitors?

Direct peers on record are Availity, Lyric (formerly ClaimsXten), MCG (Hearst Health), EviCore (Evernorth/Cigna) and Cotiviti. Emerging players are Edifecs, Infinx and Zynx Health. Broad incumbents are Change Healthcare (Optum) and Optum (UnitedHealth Group).

Does Concert have an API?

Yes. Concert provides an API that delivers machine-readable clinical criteria for automation in EHR, prior authorization, and pre-payment claim editing workflows. The API enables integration of clinical policy content into partner platforms and workflows.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Motley FoolLucid Diagnostics (LUCD) Q3 2026 Earnings Call TranscriptLucid Diagnostics reported Q3 2026 results with Medicare reimbursement for its EsoGuard test, enabling commercial acceleration. The company saw record October test volume of 1,800 tests and a 4% sequential increase in total volume to 2,871. It expects five client health plans to adopt Concert Laboratory coverage by year-end.ItbriefLyric moves headquarters to Nashville after Concert dealLyric has relocated its global headquarters to Nashville, Tennessee, following its acquisition of Concert in July 2026. The move positions the healthcare decision intelligence firm within a major US healthcare cluster, leveraging local expertise and infrastructure to support its expanding operations with over 100 health plan clients.MorningstarLucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial ResultsLucid Diagnostics reported second-quarter 2026 financial results, recognizing $1.5 million in EsoGuard revenue and processing 2,770 tests while securing a commercial coverage policy from Concert. The company posted a GAAP net loss of approximately $14.7 million due to operating expenses of $14.3 million, including stock-based compensation and deemed preferred stock dividends.PR NewswireLucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial ResultsLucid Diagnostics reported second quarter 2026 financial results, recognizing $1.5 million in EsoGuard revenue and processing 2,770 tests while securing a commercial coverage policy from Concert. The company posted a GAAP net loss of approximately $14.7 million for the period, driven by operating expenses of $14.3 million. Lucid also highlighted progress in engaging with the VA and major health systems as it awaits a Medicare coverage decision.Stock TitanLucid Diagnostics Q2 Earnings: $1.5M RevenueLucid Diagnostics reported $1.5 million in revenue for the second quarter of 2026, driven by 2,770 EsoGuard tests processed and the securing of a commercial coverage policy from Concert. The company posted a GAAP net loss of approximately $14.7 million while maintaining $33.4 million in cash as of June 30, 2026.Stock TitanLucid Diagnostics Secures Concert Coverage for EsoGuardLucid Diagnostics announced that Concert, a healthcare technology company acquired by Lyric, issued a positive coverage policy for its EsoGuard Esophageal DNA Test effective July 2026. The policy recognizes the test as medically necessary for patients meeting American College of Gastroenterology screening criteria, citing sufficient evidence of improved health outcomes. Multiple Concert client health plans have already adopted this policy, marking a significant step toward broader commercial coverage.Pulse 2.0Lyric Acquires Concert to Expand Healthcare Decision Intelligence PlatformLyric, a Philadelphia and Nashville-based healthcare decision intelligence company, has acquired Concert, a precision health payment accuracy firm that converts clinical and administrative policies into machine-readable, real-time decision tools; the two companies had been working together since 2023 with their joint solution growing nearly tenfold before the acquisition. Concert's technology addresses the accelerating complexity of healthcare payment decisions by encoding clinical evidence and policy into computable formats that flow directly into health plan and provider workflows. The integration of Concert's capabilities into Lyric42 will extend Concert's Diagnostics Module for outpatient laboratory testing across Lyric's full client base of nine of the top 10 U.S. health plans.ThemiddlemarketLyric Acquires Concert to Expand Healthcare Decision Intelligence PlatformLyric has acquired Concert to combine its proprietary machine-readable clinical policy technology with Lyric’s Healthcare Decision Intelligence Platform. This transaction aims to enhance health plans' ability to manage rising healthcare costs and improve payment accuracy amidst evolving medical therapies. The companies have previously partnered since 2023 to expand their joint Diagnostics Module for outpatient laboratory testing.MobiHealthNewsLyric acquires Concert to expand AI-enabled precision-medicine paymentsHealthcare intelligence platform Lyric announced its acquisition of precision-medicine payment technology company Concert to combine Concert's policy intelligence with Lyric's AI-enabled Lyric42 platform. The acquisition aims to enhance payment accuracy for diagnostic and genetic testing by merging clinical evidence, medical policies, coding standards, and payment rules into a unified workflow system. The companies, which established a partnership in 2023 and expanded collaboration in 2024, stated the deal will accelerate innovation and shift from reactive claims enforcement to shared standards across health plan stakeholders.citybizLyric Acquires Concert to Expand AI-Powered Healthcare Decision Intelligence PlatformLyric has acquired Concert, a healthcare technology company specializing in precision health payment accuracy, expanding its Lyric42 Healthcare Decision Intelligence Platform with Concert's technology for converting clinical policies into machine-readable formats. The acquisition enables integration of Concert's policy automation capabilities directly into health plan workflows, supporting diagnostic test ordering, claims editing, and payment integrity. The combined platform aims to help insurers improve payment accuracy while addressing rising medical costs and the rapid expansion of precision diagnostics and specialty therapies.